Cytosorbents Corp reports results for the quarter ended in June - Earnings Summary

Cytosorbents

02/08/2023 24:08

* Cytosorbents Corp  CTSO.OQ  reported a quarterly adjusted
loss
of 14 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue rose 10.9% to $9.42 million from a year ago;
analysts
expected $11.03 million. 
    * Cytosorbents Corp's reported EPS for the quarter was a
loss
of 14 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cytosorbents Corp shares had fallen by 0.6% this
quarter and
gained 130.3% so far this year.
    * The company reported a quarterly loss of $6.15 million.
    * Wall Street's median 12-month price target for
Cytosorbents Corp
is $6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 1 at 11:07 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.11          -0.14          Missed
 Mar. 31 2023      -0.13          -0.17          Missed
 Dec. 31 2022      -0.17          -0.02          Beat
 Sep. 30 2022      -0.16          -0.28          Missed